Glycoprotein B (EBV)

Glycoprotein B (EBV)

Glycoprotein B (EBV) Molekülinformation

Molecule Name
Envelope glycoprotein B, gB
Molekülalias
gB
Drug Development Progress
Anzahl der klinischen Arzneimittel2
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Target-Alias
UL55
Molekülhintergrund
Epstein-Bar Virus (EBV), also known as human herpesvirus 4, belongs to gamma herpes virus family and is a very common human virus worldwide. EBV causes infectious mononucleosis (IM) and also associates to some specific types of cancers such as Burkitt’s lymphoma (BL) and gastric carcinoma (GC). Glycoprotein B (gB) plays an important role in viral entry by binding with αvβ6/αvβ8 integrins to trigger the membrane fusion and entry process of epithelial cells, which makes it become an great target for EBV research.

Produktanfrage

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
FiztasovimabNPC-21Phase 2 ClinicalNobelpharma Co Ltd
Cytomegalovirus Infections
Details
TRL-345CMV-345; TRL-345Phase 1 ClinicalTrellis Bioscience LLC
Cytomegalovirus Infections
Details
Customer Reviews